CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $4.39 ($87,800)
- 4 Open-market sale Director sold 7,084 shares at $5.11 ($36,199)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Auditor change
- 4 Shares withheld for taxes Chief Executive Officer gave up 181 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Shares withheld for taxes Chief Executive Officer gave up 13,290 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,230 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 6,557 shares (to pay taxes)
- 4 Open-market sale Director sold 6,330 shares at $3.91 ($24,721)
- 4 Open-market sale Director sold 6,316 shares at $3.91 ($24,724)
- 4 Open-market sale Director sold 8,330 shares at $4.91 ($40,924)
- 4 Open-market sale Director sold 7,246 shares at $3.90 ($28,270)
- 4 Open-market sale Director sold 5,508 shares at $3.91 ($21,542)
Page 15 of 66 · 1,318 filings